Israeli patient receives new non-invasive treatment for epilepsy in first outside Europe
The EASEE brain stimulation system, first developed in Germany by PRECISIS, is designed to treat epilepsy without opening the skull or inserting electrodes into the brain.
An Israeli patient, Olga Moisa, underwent a pioneering non-invasive epilepsy treatment at Clalit-Beilinson Hospital, marking the first such procedure outside of Europe. The EASEE brain stimulation system, developed in Germany by PRECISIS, stimulates seizure focus in the brain externally without the need for skull opening or electrode insertion.
Dr. Idit Tamir, Director of the Functional Neurosurgery Unit, highlighted this as a significant advancement, potentially reducing seizure frequency without brain penetration. Moisa, a 42-year-old epilepsy patient for 15 years, had not responded to medication. Professor Felix Benninger, overseeing the Epilepsy Treatment Unit, explained the device's non-invasive nature.
On August 31, Moisa received treatment, experiencing no seizures since. Her son, Sasha, expressed optimism, suggesting even a 50% reduction in seizures would be beneficial. The device currently operates at a low stimulation level, with effectiveness to be fully evaluated in the coming months.
Written by urgent.news from Jerusalem Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
